Sertindole in Asian Patients With Schizophrenia

Phase 3 Completed 394 enrolled H. Lundbeck A/S

RandomizedParallel-groupDouble-blindTreatment

The purpose of this study is to assess the efficacy and safety of sertindole in patients with schizophrenia in Asia.

Evaluation	Drug	Modality	Dose	Route
Comparator	Olanzapine	Small molecule	10 mg	Other
Comparator	Olanzapine	Small molecule	15 mg	Other
Comparator	Olanzapine	Small molecule	20 mg	Other
Subject	Sertindole	Small molecule	12 mg	Other
Subject	Sertindole	Small molecule	16 mg	Other
Subject	Sertindole	Small molecule	20 mg	Other